Stockscreener 앱 받기
0.4805
69.74%
-1.1095
전일 마감가:
$1.59
열려 있는:
$0.6443
하루 거래량:
71.30M
Relative Volume:
12.21
시가총액:
$5.26M
수익:
$9.81M
순이익/손실:
$-26.16M
주가수익비율:
-0.0124
EPS:
-38.77
순현금흐름:
$-17.45M
1주 성능:
+1.88%
1개월 성능:
-53.28%
6개월 성능:
-91.17%
1년 성능:
-95.08%
1일 변동 폭
$0.4282
$0.7018
1주일 범위
$0.3445
$3.05
52주 변동 폭
$0.3445
$29.00
Reshape Lifesciences Inc Stock (RSLS) Company Profile
명칭
Reshape Lifesciences Inc
전화
949-429-6680
주소
1001 CALLE AMANECER, SAN CLEMENTE
RSLS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RSLS
Reshape Lifesciences Inc
|
0.4812 | 5.26M | 9.81M | -26.16M | -17.45M | -38.77 |
|
ABT
Abbott Laboratories
|
131.59 | 225.32B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.09 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
376.25 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.57 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.79 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Reshape Lifesciences Inc 주식(RSLS)의 최신 뉴스
Nasdaq Tumbles 100 Points; UniFirst Posts Upbeat Earnings - Benzinga
ReShape Lifesciences shareholders approve key proposals - Investing.com
Stock Market News For Apr 2, 2025 - Yahoo Finance
ReShape Lifesciences Delays Yearly Report Filing - TipRanks
Global Bariatric Surgeries Market to Hit USD 27.64 Billion - GlobeNewswire
Dow Dips Over 400 Points; ISM Manufacturing PMI Falls In March - Benzinga
Sands Capital Select Growth Fund Sold Edwards Lifesciences Corporation (EW) For Better Opportunities - Yahoo Finance
Nueva Network Launches Que-Onnda Radio in Washington DC & Boston - Yahoo Finance
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Frazier Life Sciences Welcomes Chris Aakre as Principal of Company Creation - Yahoo Finance
Why XPeng Inc. (XPEV) Went Up On Monday? - Yahoo Finance
Why Mr. Cooper Group Inc. (COOP) Went Up On Monday? - Yahoo Finance
WELL HEALTH TECHNOLOGIES CORP. EARLY WARNING NEWS RELEASE - Yahoo Finance
Analysts at Cantor, formerly headed by Lutnick, call for Kennedy's dismissal - Yahoo Finance
Lytus Technologies Adjusts Market Strategy and Transition to OTC Markets - Yahoo Finance
Novvia Group Acquires MegaChem - Yahoo Finance
ReShape Lifesciences, Allarity, Exact Sciences, CVS, AbbVie: 5 Health Care Stocks That Led Retail Message Growth Last Week - MSN
Bio-Techne Opens New Customer Experience Centre in Germany - Yahoo Finance
The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics - Yahoo Finance
Investors Heavily Search Occidental Petroleum Corporation (OXY): Here is What You Need to Know - Yahoo Finance
Pearson Expands Professional Learning Capabilities with New Skilling Partner Program - Yahoo Finance
The legal problems facing a new Trump TikTok rescue — and why they may not matter - Yahoo Finance
Is Palantir Technologies Inc. (NASDAQ:PLTR) The Best Stock to Buy and Hold for 2 Years? - Yahoo Finance
Wave Life Sciences unveils Phase II data for DMD therapy, WVE-N531 - Yahoo Finance
Duchesnay Pharmaceutical Group recognized for commitment to well-being of its employees as winner of 2025 Healthiest Workplace Award - Yahoo Finance
Wave Life Sciences (WVE) Stock Jumps 6.1%: Will It Continue to Soar? - Yahoo Finance
RSLS stock touches 52-week low at $0.49 amid sharp annual decline - Investing.com Australia
RSLS stock touches 52-week low at $0.49 amid sharp annual decline By Investing.com - Investing.com South Africa
US jet fuel imports surge as Nigeria's Dangote refinery pushes barrels west - Yahoo Finance
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FNA, AVTE, RSLS on Behalf of Shareholders - GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FNA, AVTE, RSLS on Behalf of Shareholders - GlobeNewswire Inc.
Maravai Lifesciences price target lowered to $5 from $10 at Stifel - Yahoo Finance
RESHAPE LIFESCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ReShape Lifesciences Inc.RSLS - Business Wire
ReShape Lifesciences Faces Board Resignation Challenge - TipRanks
RSLS stock touches 52-week low at $0.61 amid market challenges By Investing.com - Investing.com South Africa
RSLS stock touches 52-week low at $0.61 amid market challenges - Investing.com India
Pre-market Movers: REVB, QSI, EYEN, NAOV ... - RTTNews
REDFIN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Redfin CorporationRDFN - Business Wire
ENDO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Endo, Inc.NDOI - Business Wire
Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial - Yahoo Finance
First national perception survey of Food is Medicine programs shows strong public support - EurekAlert!
Ratio Analysis: Unpacking ReShape Lifesciences Inc (RSLS)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
ReShape Lifesciences, Allarity, Exact Sciences, CVS, AbbVie: 5 Health Care Stocks That Led Retail Message Grow - Asianet Newsable
ReShape Lifesciences® Receives Notice of Allowance for Vagus Nerve Modulation Patent Aimed at Improving Glycemic Control - Nasdaq
ReShape Lifesciences® Receives Notice of Allowance for U.S. - GlobeNewswire
ReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology - Yahoo
ReShape Lifesciences Patents Breakthrough Diabetes Neuromodulation System - Stock Titan
ReShape Lifesciences, Inc. to Host Earnings Call - ACCESS Newswire
RSLS stock touches 52-week low at $0.87 amid market challenges - Investing.com Canada
RSLS stock touches 52-week low at $0.87 amid market challenges By Investing.com - Investing.com South Africa
Global Synthetic Biosensors Market Size to Hit USD 49.87 Billion by 2032 -Coherent Market Insights - openPR
Reshape Lifesciences Inc (RSLS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.44%
0.15%
자본화:
|
볼륨(24시간):